Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 14, 1979 - Issue 7
Submit an article Journal homepage
4
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Effect of Orally Administered 15(R)-15-Methyl Prostaglandin E2 and/or an Anticholinergic Drug on Meal-induced Gastric Acid Secretion and Serum Gastrin Level in Patients with Duodenal Ulcers

S. J. Konturek Institute of Physiology, Medical Academy, Cracow, Poland
,
J. S. Swierczek Institute of Physiology, Medical Academy, Cracow, Poland
,
N. Kwiecien Institute of Physiology, Medical Academy, Cracow, Poland
,
W. Obtułowicz Institute of Physiology, Medical Academy, Cracow, Poland
,
E. Sito Institute of Physiology, Medical Academy, Cracow, Poland
&
J. Oleksy Institute of Physiology, Medical Academy, Cracow, Poland
Pages 813-819 | Received 18 Oct 1978, Accepted 02 May 1979, Published online: 23 Feb 2010

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

H. Koop, H. Schwarting, U. Eckel, J. Wagenknecht, U. Hallfeldt & R. Arnold. (1989) Influence of Chronic Rioprostil Treatment on Gastric Endocrine Function. Scandinavian Journal of Gastroenterology 24:sup164, pages 104-111.
Read now
C. B. H. W. Lamers. (1988) Hormonal Regulation of Gastric Acid in Peptic Ulcer Disease. Scandinavian Journal of Gastroenterology 23:sup146, pages 5-10.
Read now
JØRgen Rask-Madsen & Karsten Lauritsen. (1987) Enhancement of Mucosal Defence by Prostaglandins. Rationale and Clinical Experience in Ulcer Disease. Scandinavian Journal of Gastroenterology 22:sup128, pages 34-42.
Read now
JØRgen Rask-Madsen. (1987) The Role of Eicosanoids in the Gastrointestinal Tract. Scandinavian Journal of Gastroenterology 22:sup127, pages 7-19.
Read now
K. Lauritsen & J. Rask-Madsen. (1986) Prostaglandins and Clinical Experience in Peptic Ulcer Disease. Scandinavian Journal of Gastroenterology 21:sup125, pages 174-188.
Read now

Articles from other publishers (10)

Glenn R. Davis, John S. Fordtran & Esam Z. Dajani. (1988) Dose-response, meal-stimulated gastric antisecretory study of prostaglandin E1 analog, misoprostol, in man. Digestive Diseases and Sciences 33:3, pages 298-302.
Crossref
Laurence B. Katz, Thomas Genna, George H. GreeleyJrJr & David A. Shriver. (1987) Antisecretory and antigastrin effects of rioprostil in gastric fistula dogs. Digestive Diseases and Sciences 32:11, pages 1268-1274.
Crossref
Dov Wengrower, Alexander Fich, Eran Goldin, Rami Eliakim, Moshe Ligumsky & Daniel Rachmilewitz. (1987) Cytoprotective doses of arbacet with minimal antisecretory properties are not effective in duodenal ulcer healing. Digestive Diseases and Sciences 32:8, pages 857-860.
Crossref
Arthur R. Euler, Guido Tytgat, Joaquin Berenguer, Harold Brunner, David R. Wood, Janice L. Lookabaugh & Tuan D. Phan. (1987) Failure of a cytoprotective dose of arbaprostil to heal acute duodenal ulcers. Gastroenterology 92:3, pages 604-607.
Crossref
S. K. LAM. (2008) Prostaglandins for duodenal ulcer and gastric ulcer. Journal of Gastroenterology and Hepatology 1:6, pages 471-481.
Crossref
C.J Hawkey & R.P Walt. (1986) PROSTAGLANDINS FOR PEPTIC ULCER: A PROMISE UNFULFILLED. The Lancet 328:8515, pages 1084-1087.
Crossref
Frank J. Thomas, Michael A. Koss, Daniel L. Hogan & Jon I. Isenberg. (1986) Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer. The American Journal of Medicine 81:2, pages 44-49.
Crossref
C.J. Hawkey & D.S. Rampton. (1985) Prostaglandins and the gastrointestinal mucosa: Are they important in its function, disease, or treatment?. Gastroenterology 89:5, pages 1162-1188.
Crossref
T. S. Gaginella, R. J. Bertko, R. K. M. M�ller, H. Gallo-Torres & A. C. Sullivan. (1985) Inhibition of canine gastric secretion by the prostanoid Ro 22-6923. Digestive Diseases and Sciences 30:4, pages 340-345.
Crossref
James A. Bristol & James F. Long. 1981. Annual Reports in Medicinal Chemistry Volume 16. Annual Reports in Medicinal Chemistry Volume 16 83 91 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.